Belcher: Shows a model of graphene sheet, rolled into a nanotube. M13 to pick up nanotubes. And wired to current collectors. #AACR17
10:43am April 2nd 2017 via Hootsuite
Belcher: Uses a model of M13 bacteriophage. (With LEDs!) engineering M13 for solar cells and batteries. #AACR17
Belcher: Working on imaging and therapeutics; 'give biology the oppy to work with the entire periodic table' #AACR17
10:42am April 2nd 2017 via Hootsuite
Belcher: Has as large a disclosure slide as George Church (but on materials side). Shows abalone shell - 50M years to get there #AACR17
10:41am April 2nd 2017 via Hootsuite
Belcher: A similar problem - brings up a 3D printed of a 3cm tumor, Stg III-IV. Now - 0.5cm finding - reduce 50% ov ca mortality #AACR17
10:39am April 2nd 2017 via Hootsuite
Belcher: "It's not rocket science - or is it?" 170M particles in space that we're tracking, 1cm in size (!!) #AACR17
10:38am April 2nd 2017 via Hootsuite
Belcher: Because this (cancer research) 'is the most important problem'. A material science perspective. #AACR17
Belcher: Has worked prior in solar cells and catalysts; now at the Koch Inst, wroking on cancer. "I was very intimidated" #AACR17
10:37am April 2nd 2017 via Hootsuite
Belcher: Has studied nanomaterials; 100K's of atoms, controlling where atoms are placed, changing their properties. #AACR17
10:36am April 2nd 2017 via Hootsuite
Angela Belcher (MIT MA) New approaches for finding tiny tumors: towards early detection and trtmnt of ovariant cancer #AACR17
Davidson: #AACR17 The magnitude of the proposed cuts 'are truly appalling'. Would severely hamper efforts in the future.
10:26am April 2nd 2017 via Hootsuite
#AACR17 No other organization has the scope, expertise, and drive to meet (the challenge of changing the face of cancer).
10:23am April 2nd 2017 via Hootsuite
Caligiuri #AACR17 Project Genie - https://t.co/hqnoSo6j0g will impact treatment, prevention, pt involvement.
10:21am April 2nd 2017 via Hootsuite
Calligiuri #AACR17 - Big data will transform our understanding of cancer, just like it has transformed our experience of buying a book.
Video at #AACR17 now with several survivor stories; one TNBC right before the holidays (and her 39th birthday).
10:19am April 2nd 2017 via Hootsuite
Davidson: #AACR17 Have high-school and post-graduate programs; encouraging engagement with senior researchers.
Davidson: #AACR17 All outstanding opportunities to take these therapies from the bench to the bedside - and back again.
10:18am April 2nd 2017 via Hootsuite
TIL here at #AACR17 the @AACR organization has over 220 staff. Nancy Davidson: 'we now have several well-defined screening technologies'
10:17am April 2nd 2017 via Hootsuite
RT @AlexandraSurcel: Advice from Mina Bissell @AACR #AACR17 #MentoringAdvice https://t.co/VoZ0QHiWup
10:15am April 2nd 2017 via Hootsuite
Nancy Davidson (current president AACR) #AACR17 Announces publishing book 'Landmarks in Cancer 1907-2017' - video shown.
10:14am April 2nd 2017 via Hootsuite
Kimmel: #AACR17 Seems an upside-down world, where funds are being cut. 20y ago he led the march for increasing funding.
10:08am April 2nd 2017 via Hootsuite
Kimmel: #AACR17 In the fashion industry, acted in the best interests of others, took risk. After 20y of progress - but disppt'd w/present
10:06am April 2nd 2017 via Hootsuite
RT @gocheval: "You have only one life, do something good with it" Mina Bissell's signature advice #AACR17 https://t.co/1DrOBg96rw
10:04am April 2nd 2017 via Hootsuite
#AACR17 Distinguished Public Service award - Sidney Kimmel, philantropist. $25M for Stand Up to Cancer @SU2C to $150M to Hopkins
10:03am April 2nd 2017 via Hootsuite
Reese: #AACR17 "Our missions are closely aligned."
10:00am April 2nd 2017 via Hootsuite
Dr. David Reese at #AACR17 from Amgen - announcement of $1M unrestricted funds for AACR to advance research.
9:55am April 2nd 2017 via Hootsuite
Croce: #AACR17 Coding genome at <2%; rest is not 'junk' - non-coding can be involved w/oncogenesis.
9:51am April 2nd 2017 via Hootsuite
Croce: #AACR17 First gene to affect epigenetic status as an oncogene. In CLL, mIR-15a and several others lost in CLL - non-coding genome
9:49am April 2nd 2017 via Hootsuite
Croce: #AACR17 With a talented post-doc, cloned bcr/abl. Then characterized ALL1 (now called CML1), also partial duplication
9:48am April 2nd 2017 via Hootsuite
Croce: #AACR17 Disregulation of MYC oncogene by chromosomal translocation in Burkitt's lymphoma; the underlying principle for targeted Rx
9:47am April 2nd 2017 via Hootsuite
Foti award at #AACR17 for Leadership and Extraordinary achievements - Carlo Croce of The Ohio State Univ
9:46am April 2nd 2017 via Hootsuite
Whelan: #AACR17 Now back onto clin trials for PrCa; very exciting time, the word 'hope' is used with new diagnostic tests.
9:41am April 2nd 2017 via Hootsuite
Whelan: #AACR17 Without DRE and PSA, backed away from over-diagnosis. 'We need to engage the whole diagnostic field'. Chose std of care
9:40am April 2nd 2017 via Hootsuite
Whelan: #AACR17 A year ago - mPr Ca dx, All missed by primary care, military care, all followed preventative services task force.
9:39am April 2nd 2017 via Hootsuite
Whelan: #AACR17 Felt that advocacy was the best way to learn; AACR has a scientist-survivor program. https://t.co/x17ATaxnyx
Whelan: #AACR17 10y ago, rare lymphoplasmocytic lymphoma; at the time of his Dx, all experimental. Most relapse refractory, buying time.
9:38am April 2nd 2017 via Hootsuite
Award at #AACR17 for Distinguished Public Service - Jack Whelan, a cancer research advocate.
9:35am April 2nd 2017 via Hootsuite
Bissell: #AACR17 "Keep your integrity and empathy; you persist in order to achieve." Also - read Susan Lindquist https://t.co/4Z97RhVVO1
9:32am April 2nd 2017 via Hootsuite
Bissell: #AACR17 'Don't be arrogant - it kills curiosity and passion.' We know a lot - but not enough. "Question, question, question."
9:31am April 2nd 2017 via Hootsuite
Lifetime achievement award at #AACR17 - Mina Bissell (Lawrence Berkeley NL) for mentorship, for contributions. Don't ask what a cell can do.
9:30am April 2nd 2017 via Hootsuite
Hello #AACR17 - welcome to D.C.! Twitter followers - majority of messages thru April 5 https://t.co/ijKC1Hj7Km https://t.co/sNG7aiOvME
9:19am April 2nd 2017 via Hootsuite
RT @cvdelucaPVI: @RimmPathology offering thoughts on pdl1 diagnostics for #Immunotherapy #PeerView #AACR17 https://t.co/UcePHNzwbu
8:23pm April 1st 2017 via Hootsuite
@OscamoTech For sure - since @seracare is a small company, will be spending a lot of time at #AACR17 at the booth.… https://t.co/LdpVlVCa17
8:21pm April 1st 2017 via Hootsuite in reply to OscamoTech
10x Genomics Launches New Immunology Kit for VDJ Analysis as It Eyes Translational Medicine Market | GenomeWeb ($) https://t.co/kUvT6AVL8A
4:27pm March 31st 2017 via Hootsuite
“I would trade all of my technology for an afternoon with Socrates.” - Steve Jobs
12:56pm March 31st 2017 via Hootsuite
Liquid Biopsy Startup Freenome Using Recently Raised Funds to Show Clinical Validity, Utility | GenomeWeb ($) https://t.co/KnYK5UCiyI
11:26am March 31st 2017 via Hootsuite
.@archerdxinc How cool would it be to get your face on a ruble note at #AACR17 (just keepin' it real!)
10:49am March 31st 2017 via Hootsuite in reply to archerdxinc
.@agbt Ha ha - made me look! #AGBT17 was great - nice photos! https://t.co/bzcmW06Q37
10:46am March 31st 2017 via Hootsuite
Find @SeraCare at #AACR17 - trial offer for FFPE RNA fusion reference material v2 for clinical NGS https://t.co/wSI94G6HMd
9:27am March 31st 2017 via Hootsuite
Sophia Genetics Inks Deals With African Hospitals to Bring Clinical Genomics to Patients | GenomeWeb ($) https://t.co/8JbIKDEaZd
9:30pm March 29th 2017 via Hootsuite
